Although the Inflation Reduction Act (IRA) tried to address the high cost of prescription drugs, this Forbes article rightly points out the unintended consequences of its "pill penalty.” In the short term, this pill penalty raises the cost of prescription tablets and capsules; in the long term, it stifles important pharmaceutical innovation and research into convenient, easy-to-use pills.